Bacs-Kiskun County Teaching Hospital Trials

Bacs-Kiskun County Teaching Hospital	Welcome, Profile Billing Logout

Bacs-Kiskun County Teaching Hospital

Welcome, Profile Billing Logout

0 Trials

4 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Berta, B

CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting

2499

Europe, Canada, RoW

zalunfiban, RUC-4, Placebo

CeleCor Therapeutics, CeleCor Therapeutics, Inc.

ST-elevation Myocardial Infarction (STEMI)

12/24

SLIM, NCT03562572: FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease

Recruiting

N/A

476

Europe, RoW

Ischemia driven revascularization, Usual care group

Zuyderland Medisch Centrum, Maastricht University Medical Center, Radboud University Medical Center, Jeroen Bosch Ziekenhuis, VieCuri Medical Centre, Gottsegen György Országos Kardiológiai Intézet, Bács-Kiskun County Teaching Hospital, Brno University Hospital, Szeged University

Coronary Artery Disease, NSTEMI - Non-ST Segment Elevation MI, Fractional Flow Reserve, Myocardial, Myocardial Revascularization, Percutaneous Coronary Intervention

12/25

01/28

Arslan, F

CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting

2499

Europe, Canada, RoW

zalunfiban, RUC-4, Placebo

CeleCor Therapeutics, CeleCor Therapeutics, Inc.

ST-elevation Myocardial Infarction (STEMI)

12/24

Margo, M

CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting

2499

Europe, Canada, RoW

zalunfiban, RUC-4, Placebo

CeleCor Therapeutics, CeleCor Therapeutics, Inc.

ST-elevation Myocardial Infarction (STEMI)

12/24

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Berta, B

CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting

2499

Europe, Canada, RoW

zalunfiban, RUC-4, Placebo

CeleCor Therapeutics, CeleCor Therapeutics, Inc.

ST-elevation Myocardial Infarction (STEMI)

12/24

SLIM, NCT03562572: FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease

Recruiting

N/A

476

Europe, RoW

Ischemia driven revascularization, Usual care group

Coronary Artery Disease, NSTEMI - Non-ST Segment Elevation MI, Fractional Flow Reserve, Myocardial, Myocardial Revascularization, Percutaneous Coronary Intervention

12/25

01/28

Arslan, F

CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting

2499

Europe, Canada, RoW

zalunfiban, RUC-4, Placebo

CeleCor Therapeutics, CeleCor Therapeutics, Inc.

ST-elevation Myocardial Infarction (STEMI)

12/24

Margo, M

CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting

2499

Europe, Canada, RoW

zalunfiban, RUC-4, Placebo

CeleCor Therapeutics, CeleCor Therapeutics, Inc.

ST-elevation Myocardial Infarction (STEMI)

12/24

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites